David A. Siegel Liva Nova PLC Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Liva Nova PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 99,645 shares of LIVN stock, worth $5.23 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
99,645
Previous 115,245
13.54%
Holding current value
$5.23 Million
Previous $6.45 Million
15.27%
% of portfolio
0.01%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding LIVN
# of Institutions
249Shares Held
56.1MCall Options Held
566KPut Options Held
506K-
Black Rock Inc. New York, NY6.9MShares$363 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA5.98MShares$314 Million0.24% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$146 Million0.07% of portfolio
-
State Street Corp Boston, MA2.05MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$98 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.81B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...